Aileen Wang
Director of Finance/CFO chez CLOVER BIOPHARMACEUTICALS, LTD.
Profil
Aileen Wang is currently the Chief Financial Officer at Clover Biopharmaceuticals Ltd.
She previously worked at Novartis Gene Therapies, Inc. as the Head-Core Business Planning & Analysis.
Ms. Wang holds an MBA from The Pennsylvania State University and an undergraduate degree from Shanghai Jiao Tong University.
Postes actifs de Aileen Wang
| Sociétés | Poste | Début |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Director of Finance/CFO | 01/07/2022 |
Anciens postes connus de Aileen Wang
| Sociétés | Poste | Fin |
|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | - |
Formation de Aileen Wang
| The Pennsylvania State University | Masters Business Admin |
| Shanghai Jiao Tong University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
